Published in Br J Ophthalmol on October 01, 1999
Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival. Clin Exp Metastasis (2011) 0.80
Intra-orbital malignant melanoma: role of MR imaging (a case report and literature review). Glob J Health Sci (2011) 0.78
Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85
Malignant melanoma and exposure to fluorescent lighting at work. Lancet (1982) 2.28
Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol (1978) 2.08
Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology (1989) 1.82
Survival of patients with metastases from uveal melanoma. Ophthalmology (1991) 1.80
Familial uveal melanoma. Clinical observations on 56 patients. Arch Ophthalmol (1996) 1.67
Sunlight and cancer. Cancer Causes Control (1997) 1.66
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62
Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res (1994) 1.57
Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology (1982) 1.51
Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J (1968) 1.50
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol (1973) 1.47
Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol (1993) 1.45
Problems in the diagnosis of malignant melanomas of the choroid and ciliary body. The 1972 Arthur J. Bedell Lecture. Am J Ophthalmol (1973) 1.43
Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst (1985) 1.41
The epidemiology of ophthalmic malignancies in New York State. Ophthalmology (1990) 1.33
Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res (1990) 1.32
Microvessel count predicts survival in uveal melanoma. Cancer Res (1996) 1.27
Histogenesis of malignant melanomas of the uvea. II. Relationship of uveal nevi to malignant melanomas. Cancer (1967) 1.21
Melanomas of eye: stability of rates. Am J Epidemiol (1981) 1.17
Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med (1990) 1.15
An inquiry into the epidemiology of melanoma. Am J Epidemiol (1985) 1.10
Epidemiology of eye cancer in adults in England and Wales, 1962-1977. Am J Epidemiol (1983) 1.07
Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res (1985) 1.05
Ocular and oculodermal melanocytosis associated with uveal melanoma. Ophthalmology (1983) 1.03
Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res (1994) 1.03
Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers. Am J Ophthalmol (1980) 1.00
Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer (1995) 1.00
Socio-economic status, indoor and outdoor work, and malignant melanoma. Int J Cancer (1984) 1.00
Solar ultraviolet radiation and ocular disease: a review of the epidemiological and experimental evidence. Ophthalmic Epidemiol (1994) 0.99
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 0.99
Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl (1977) 0.98
Case-control study of female hormones and eye melanoma. Cancer Res (1989) 0.97
Uveal melanomas: correlation of cytologic features with prognosis. Cancer (1978) 0.96
Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?. Arch Ophthalmol (1996) 0.95
Loss of alleles at polymorphic loci on chromosome 2 in uveal melanoma. Cancer Genet Cytogenet (1986) 0.94
Grouping occupations according to carcinogenic potential: occupation clusters from an exposure linkage system. Am J Epidemiol (1983) 0.92
Uveal malignant melanoma in three generations of the same family. Am J Ophthalmol (1979) 0.92
Adenocarcinoma arising from the epithelium of the iris and ciliary body. Int Ophthalmol Clin (1980) 0.92
Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br J Cancer (1999) 0.92
Two subclones in a case of uveal melanoma. Relevance of monosomy 3 and multiplication of chromosome 8q. Cancer Genet Cytogenet (1994) 0.92
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. Natl Cancer Inst Monogr (1985) 0.91
Histology, survivorship and related factors in the epidemiology of eye cancers. Am J Epidemiol (1973) 0.91
Color as a risk factor in iris melanoma. Am J Ophthalmol (1984) 0.90
Familial intraocular malignant melanoma: a case report. Cancer (1978) 0.88
The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II. Am J Ophthalmol (1997) 0.88
Quantitative analysis of the Callender classification of uveal melanoma cells. Arch Ophthalmol (1977) 0.87
Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer (1987) 0.86
Black-white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health (1994) 0.86
Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol (1993) 0.86
Familial uveal melanoma. Br J Ophthalmol (1988) 0.86
Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol (1994) 0.85
Malignant melanoma associated with breast cancer. South Med J (1980) 0.85
Possible relation between HLA and ABO type and prognosis of uveal melanoma. Doc Ophthalmol (1992) 0.84
Trends in eye cancer mortality among adults in the USA and England and Wales. Br J Cancer (1996) 0.83
Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution. Radiat Res (1997) 0.83
Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer (1995) 0.83
Congenital malignant melanoma of the eye. Cancer (1991) 0.83
Uveal melanoma: is solar ultraviolet radiation a risk factor? Ophthalmic Epidemiol (1994) 0.83
Ocular malignant melanoma in South African blacks. Br J Ophthalmol (1981) 0.82
Other cancers in uveal melanoma patients and their families. Am J Ophthalmol (1989) 0.82
Congenital melanoma of the anterior uvea. Arch Ophthalmol (1966) 0.81
Uveal melanoma, hormonal and reproductive factors in women. Cancer Res (1991) 0.81
Choroidal malignant melanoma in siblings. Am J Ophthalmol (1983) 0.80
Occupation and risk of uveal melanoma. An exploratory study. Cancer (1992) 0.80
The association of viruses with urveal melanoma. Trans Am Ophthalmol Soc (1979) 0.80
Epidemiology of intraocular melanoma. Recent Results Cancer Res (1986) 0.79
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol (1983) 0.79
Uveal melanoma. Int Ophthalmol Clin (1993) 0.78
Ocular melanoma in families with dysplastic nevus syndrome. J Am Acad Dermatol (1990) 0.78
Choroidal melanocytic tumor observed for 41 years before enucleation. Arch Ophthalmol (1978) 0.77
Immunogenetic heterogeneity of uveal melanoma. Cancer Detect Prev (1988) 0.76
An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology (1993) 0.76
Familial uveal melanoma. Am J Ophthalmol (1994) 0.76
Smoking and the risk of early metastases from uveal melanoma. Ophthalmology (1992) 0.76
[Familial uveal melanoma]. Klin Monbl Augenheilkd (1995) 0.76
Place of birth and incidence of ocular melanoma in the United States. Int J Cancer (1988) 0.76
Bilateral primary uveal melanoma. Bad luck or bad genes? Ophthalmology (1996) 0.76
Interdependence of eye and hair colour, skin type and skin pigmentation in a Caucasian population. Acta Derm Venereol (1998) 0.76
Modern methods in the diagnosis of uveal melanomas. Trans Ophthalmol Soc U K (1977) 0.75
Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg (2007) 2.19
Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes. Am J Ophthalmol (1993) 1.83
Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res (1995) 1.83
C-reactive protein. A clinical marker in community-acquired pneumonia. Chest (1995) 1.77
Comparison of MTT and ATP-based assays for the measurement of viable cell number. J Biolumin Chemilumin (1995) 1.67
Axon deviation in the human lamina cribrosa. Br J Ophthalmol (1998) 1.49
Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol (2002) 1.49
Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol (1997) 1.47
Phagocyte function and cytokine production in community acquired pneumonia. Thorax (1994) 1.35
Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol (2000) 1.33
Radiological and clinicopathological features of orbital xanthogranuloma. Br J Ophthalmol (2000) 1.32
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer (2011) 1.30
Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol (2009) 1.26
Is the first day postoperative review necessary after cataract extraction? Br J Ophthalmol (1995) 1.16
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol (2000) 1.16
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer (2003) 1.16
Prognostic value of measurement of elastosis in breast carcinoma. J Clin Pathol (1981) 1.13
Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev (2000) 1.11
The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin. Br J Ophthalmol (2000) 1.10
Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med (1994) 1.10
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs (1998) 1.08
Quantitation of the granuloma fraction in leprosy skin biopsies by planimetry. Int J Lepr Other Mycobact Dis (1985) 1.08
Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer (2007) 1.08
Ring melanoma--a rare cause of refractory glaucoma. Br J Ophthalmol (1999) 1.06
Identification of markers of prostate cancer progression using candidate gene expression. Br J Cancer (2011) 1.04
The ex vivo chemosensitivity profile of choroidal melanoma. Anticancer Drugs (1997) 1.03
Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol (2005) 1.01
Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J Clin Pathol (1994) 0.99
Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay. Eur J Surg Oncol (1993) 0.98
Histological fate of cortical bone autografts in the middle ear. Clin Otolaryngol Allied Sci (1995) 0.97
Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. Ann Diagn Pathol (2001) 0.96
Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol (2002) 0.96
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol (1999) 0.95
Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye (Lond) (1997) 0.94
Predictive power of screening tests for metastasis in uveal melanoma. Eye (Lond) (1998) 0.94
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) (2006) 0.93
Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br J Cancer (1999) 0.92
An intralenticular foreign body and a clear lens. Br J Ophthalmol (1993) 0.92
A large rapidly growing pilomatrixoma on a lower eyelid. Br J Ophthalmol (2000) 0.92
Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci (2001) 0.91
Studies of cell death (apoptosis) and cell division in leprosy granulomas. Int J Lepr Other Mycobact Dis (1986) 0.90
Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. Br J Cancer (2005) 0.90
Establishment of a human in vitro model of the outer blood-retinal barrier. J Anat (2007) 0.89
Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit. Ophthalmology (2001) 0.88
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy. Br J Cancer (2010) 0.88
New model of conjunctival scarring in the mouse eye. Br J Ophthalmol (1998) 0.88
Transmission and protection in leprosy: indications of the role of mucosal immunity. Lepr Rev (1997) 0.87
Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity. Biochem Biophys Res Commun (1994) 0.87
Limbal vernal keratoconjunctivitis in the tropics. Ophthalmology (1998) 0.87
TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies. J Biolumin Chemilumin (1995) 0.87
Measurement of phagocyte chemiluminescence in a microtitre plate format. J Immunol Methods (1988) 0.87
Persistence of acanthamoeba antigen following acanthamoeba keratitis. Br J Ophthalmol (2001) 0.86
The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients. Lepr Rev (1988) 0.86
Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res (2001) 0.86
The prognostic significance of c-myc oncogene expression in uveal melanoma. Melanoma Res (1998) 0.86
Multifocal choroiditis: clinicopathologic correlation. Arch Ophthalmol (1998) 0.86
Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology (2001) 0.85
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial. Clin Cancer Res (1997) 0.85
Diabetic cataract removal: postoperative progression of maculopathy--growth factor and clinical analysis. Br J Ophthalmol (2006) 0.85
Targeting EGFR and PI3K pathways in ovarian cancer. Br J Cancer (2013) 0.85
Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci (1993) 0.84
No-needle one-quadrant sub-tenon anaesthesia for panretinal photocoagulation. Eye (Lond) (1993) 0.84
The immunoalkaline phosphatase technique in immunohistochemistry: the effect of permanganate-oxalate melanin bleaching upon four final reaction products. Br J Biomed Sci (1996) 0.83
Uveal melanoma: is solar ultraviolet radiation a risk factor? Ophthalmic Epidemiol (1994) 0.83
Preservation of keratin expression in oral mucosa using a novel transport medium. J Oral Pathol Med (1992) 0.82
Cell cycle and melanoma--two different tumours from the same cell type. J Pathol (2000) 0.82
Eye involvement mimicking scleritis in a patient with chronic lymphocytic leukaemia. Br J Ophthalmol (2005) 0.82
A clinical, histopathological, and genetic study of Avellino corneal dystrophy in British families. Br J Ophthalmol (2003) 0.82
The influence of killed Mycobacterium leprae and other mycobacteria on opsonized yeast phagocytosis. Clin Exp Immunol (1986) 0.81
Measurement of phagocyte chemiluminescence using a microtitre plate luminometer. J Biolumin Chemilumin (1989) 0.81
Impairment of vasomotor reflexes in the fingertips of leprosy patients. J Neurol Neurosurg Psychiatry (1991) 0.81
Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay. Breast Cancer Res Treat (1996) 0.81
Observational and cost analysis of the implementation of breast cancer sentinel node intraoperative molecular diagnosis. J Clin Pathol (2010) 0.80
Blood flow velocity in cutaneous lesions of leprosy. Int J Lepr Other Mycobact Dis (1988) 0.80
Side effects of photon and proton radiotherapy for ocular melanoma. Front Radiat Ther Oncol (1997) 0.80
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C. Br J Cancer (2003) 0.80
The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay. Anticancer Drugs (1994) 0.79
Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. J Pathol (2000) 0.79
Mucosal immunity to mycobacteria in leprosy patients and their contacts. Lepr Rev (1988) 0.79
Histology of xanthelasma lesion treated by argon laser photocoagulation. Eye (Lond) (1998) 0.79
The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma. Anticancer Drugs (2000) 0.78
The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies. Int J Clin Lab Res (1996) 0.78
Effect of salmeterol on polymorphonuclear leukocyte (PMNL) chemiluminescence in vitro. J Biolumin Chemilumin (1993) 0.78
Recruiting donors for autopsy based cancer research. J Med Ethics (2005) 0.77
Monocyte aggregation around agarose beads in collagen gels: a 3-dimensional model of early granuloma formation? J Immunol Methods (1995) 0.77
Proton beam therapy and iris neovascularisation in uveal melanoma. Eye (Lond) (2005) 0.77
Cystic epithelial ingrowth as a late complication of penetrating keratoplasty. Arch Ophthalmol (1999) 0.77
Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma. J Pathol (2000) 0.76
The site of the autoantigen in dysthyroid eye disease: a significant negative. Eye (Lond) (1993) 0.76
Impairment of fingertip vasomotor reflexes in leprosy patients and apparently healthy contacts. Int J Lepr Other Mycobact Dis (1991) 0.76
Undefined high-power fields. Lancet (1996) 0.75
Comment: Assessment of histological response to treatment. Lepr Rev (1990) 0.75
Tumor chemosensitivity and chemoresistance assays. Cancer (1996) 0.75